Virginia Prepares to Accept Applications for a Single Medical Cannabis License for Health Service Area 1, Which Includes the Shenandoah Valley - foleyhoag.com
Virginia is opening applications for a single medical cannabis license for Health Service Area 1 (Shenandoah Valley).
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 1, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Pharmaceutical manufacturers and cannabis companies interested in operating in Health Service Area 1 of Virginia. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text; check the official Virginia Board of Pharmacy or Department of Health Professions website for the application deadline.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Virginia is preparing to accept applications for a single medical cannabis license for Health Service Area 1, which includes the Shenandoah Valley.
Who it affects
Pharmaceutical manufacturers and cannabis companies interested in operating in Health Service Area 1 of Virginia.
What you must do
Prepare and submit an application for the single medical cannabis license for Health Service Area 1 before the application window closes.
Deadline
Not specified in the provided text; check the official Virginia Board of Pharmacy or Department of Health Professions website for the application deadline.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Court bans Florida compounder from all manufacturing until it can meet FDA requirements - fiercepharma.com
- Court of Appeals Affirms Judgment that Struck Down Rule Mandating Price Disclosure in Pharmaceutical Ads - hklaw.com
- FDA finalizes rule change allowing mail-order abortion pills - pbs.org
- FDA sends warning letter to Regener-Eyes for cGMP violations, unapproved new drugs - Glance by Eyes On Eyecare
- FDA warning letter flags serious violations at New Jersey manufacturing facility for GLP-1 weight loss jabs - cleanroomtechnology.com